CMS Open Payments · Program Year 2024
Wyoming
Wyoming received $1,584,491.64 in pharmaceutical-industry payments to 788 physicians and 2 teaching hospitals across 11,098 transactions.
- $1.6M
- Total payments
- $1.4M
- To physicians
- $13.7K
- To teaching hospitals
- #51
- of 59 states
In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $1.6M in payments to 788 physicians and 2 teaching hospitals in Wyoming. That ranks Wyoming #51 of 59 states and territories (0.0% of the US total), averaging $1.7K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
The verdict
Wyoming pairs modest payment volume with an overwhelmingly physician-directed payment mix.
- #51
- of 59 states
- 0.0%
- of the national total
- 86.7%
- to physicians vs. hospitals
- 788
- physicians paid
What the Data Shows for Wyoming
Wyoming sits in the lower-volume tercile at #51 of 59 (0.0% of US dollars). The PY2024 file still records $1,584,491.64 across 11,098 transactions.
The distinctive cut versus volume is the physician share: 86.7% of dollars to 788 physicians ($1.7K each). Average transaction $142.77. Leading nature of payment: "Royalty or License" at $654.6K (41.3% of the state file; top-three natures 69.9%).
Wyoming sits in the 15th percentile (lower-volume tier). Just above: Alaska ($1.6M). Just below: Vermont ($1.5M). For context: top-ranked California ($342.4M) is 216.1× larger than Wyoming. CMS Sunshine Act framework and methodology.
Physician vs Hospital Payments
How pharmaceutical payments in Wyoming are distributed between physicians and teaching hospitals.
Physician Payments
$1.4M
86.7% of total · 788 recipients · $1.7K avg
Teaching Hospital Payments
$13.7K
0.9% of total · 2 hospitals · $6.9K avg
Payment Breakdown by Type
Wyoming has 12 types of pharmaceutical payments. "Royalty or License" accounts for 41.3%.
Nature concentration in Wyoming
Top three Open Payments natures are 69.9% of state dollars; residual is every other reported nature
Payment categories in Wyoming
Top categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of State |
|---|---|---|---|
| Royalty or License | $654.6K | 11 | 41.3% |
| Food and Beverage | $254.9K | 10,040 | 16.1% |
| Consulting Fee | $197.8K | 105 | 12.5% |
| Compensation for Services Other Than Consulting | $194.1K | 104 | 12.2% |
| Travel and Lodging | $143.2K | 469 | 9.0% |
| Education | $110.6K | 274 | 7.0% |
| Long-Term Medical Supply or Device Loan | $8.6K | 15 | 0.5% |
| Gift | $7.4K | 55 | 0.5% |
| Debt Forgiveness | $6.5K | 9 | 0.4% |
| Grant | $6.4K | 2 | 0.4% |
| Honoraria | $281.62 | 6 | 0.0% |
| Entertainment | $208.63 | 8 | 0.0% |
Read with this Wyoming Open Payments read
Volume neighbors, physician-share peers, and the national nature catalog, not the same three guides on every state page.
- Next higher total: Alaska ($1.6M)
- Next lower total: Vermont ($1.5M)
- Nearest physician-share mix: Rhode Island (86.4% to physicians)
- Nearest physician-share mix: Maine (87.2% to physicians)
- Nearest physician-share mix: Maryland (87.3% to physicians)
- National catalog for leading nature here: Royalty or License (41.3% of Wyoming)
- State payment rankings (includes Wyoming at #51)
- How Open Payments natures are defined
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Read our methodology - how this data is sourced, computed, and verified.
Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024
What Wyoming totals can and cannot tell you
The aggregate payment figure for Wyoming measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.
Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.